| Product Name | LACTEL |
| Chemical / Trade Name | Poly(lactide-co-glycolide) (PLGA)/ Poly-lactide (PLA) polymers |
| Description | These biodegradable polymers produced from glycolide, lactide, and e-caprolactone monomers. These three cyclic monomers can be assembled into a wide variety of polymers and copolymers. Polymer properties can be tailored from soft elastomeric materials to rigid
engineering plastics. In addition to mechanical properties, other polymer properties – including degradation rate, hydrophilicity, and solubility – can be customized for individual applications. Poly (D, L- lactide), Poly (D,L-lactide, co-glycolide acid), block polymers, etc. are used as a controlled and sustained delivery system of drug substances with continuous effect from one week to several months. These polymers are usually used to do away with multiple injections, high toxicity and to achieve the desired therapeutic effect. |
| Product Application |
LACTEL polymers can be tailored through
the control of monomer composition, end-group chemistry, and molecular weight to meet your specific application needs
and to provide a wide range of resorption rates. Drug delivery : Parenteral controlled delivery, Sustained release or depot medicines (slow-release) - such as small substances, peptides, therapeutic proteins, hormones, antibiotics, etc. - formulated using PLGA-grade injectable polymers. Medical devices containing PLGA polymers like such as biodegradable sutures, interference screws, stent coatings, wound dressings, and more. Tissue Engineering |
| Molecule specific | |
| Regulatory | USDMF |
| Packing | Customized Packaging is available |